Benchling Competitive Intelligence & Landscape

Benchling (benchling.com) is a leading cloud-based platform designed for biotechnology research and development (R&D). Its core offering is a unified platform that connects predictive models, structured data, and wet lab execution, facilitating faster breakthroughs in science [https://benchling.com/]. The company’s mission is to unlock the power of biotechnology by helping scientists unite data, automation, and AI to accelerate the creation of new products and discoveries [https://www.benchling.com/about-us].

Benchling provides a comprehensive suite of tools including a collaborative, cloud-based notebook for planning, recording, and sharing experiments, automated workflows, and advanced AI capabilities [https://benchling.com/]. The platform allows for the modeling and tracking of diverse scientific data, such as biomolecules, small molecules, cell lines, animals, and reagents, creating a unified data model that powers computational science [https://benchling.com/]. It also offers out-of-the-box integrations, custom app development, and connections to instruments and other software, ensuring an open and flexible R&D ecosystem [https://benchling.com/].

Benchling's target market spans teams across discovery, pre-clinical development, and process development, serving over 1,300 leading biotech organizations [https://www.benchling.com/platform][https://www.benchling.com/ai]. Specific solutions cater to bioresearch, bioprocess, biologics, in vivo studies, and automation, with specialized support for cutting-edge modalities like gene therapy, cell therapy, antibodies and proteins, RNA therapeutics, agritech, industrial, and microbial strains [https://benchling.com/]. Additionally, Benchling offers free access to its electronic lab notebook and molecular biology software for academics to modernize their science through seamless collaboration and effective data management [https://www.benchling.com/academic].

The company was co-founded by CEO Sajith Wickramasekara and Ashu Singhal [https://www.benchling.com/leadership]. While specific details about the founding year and headquarters are not explicitly stated in the provided text, the company is actively hiring and building a team of talent in tech and science [https://www.benchling.com/careers][https://www.benchling.com/leadership].

Benchling is committed to empowering scientists by providing the advanced tools necessary to keep pace with the rapidly evolving landscape of modern R&D, ultimately striving to bring life-changing products to market faster [https://www.benchling.com/about-us][https://www.benchling.com/careers].

Benchling provides a cloud-based platform for biotech R&D, offering tailored solutions rather than public pricing plans [benchling.com/pricing]. Their product suite is designed to accommodate organizations from startups to large industry leaders, with pricing customized to specific business needs [benchling.com/pricing]. This approach includes add-on capabilities and scientific accelerators to reduce time-to-value [benchling.com/pricing].

For early-stage biotech companies, Benchling offers a specialized program called Benchling for Startups, which provides a quick-start package at a tailored price point [benchling.com/startups]. This initiative, announced in September 2019, aims to accelerate innovation for new biotech ventures [benchling.com/blog/announcing-two-new-editions-to-accelerate-life-science-innovation-benchling-for-institutions-and-benchling-for-startups]. Additionally, academic institutions can utilize Benchling for Academics, a completely free offering designed to modernize science through collaboration and data management [benchling.com/academic].

The core Benchling platform integrates scientific data, automation, and AI to streamline R&D workflows [benchling.com/product-overview]. Key products include Benchling Bioresearch, which provides a shared space for designing and managing experiments, complex biomolecules, and workflows [benchling.com/bioresearch], and Benchling AI, offering features, agents, and models to enhance efficiency and uncover insights directly within the notebook interface [benchling.com/ai, benchling.com/main-services-agreement]. The platform supports various modalities like gene therapy, cell therapy, and antibodies, and also offers pre-built industry solutions to accelerate implementation [benchling.com/solutions].

All Benchling licenses include comprehensive product support, providing responsive assistance via email, web, and within the application [benchling.com/customer-success]. Customers also gain access to self-serve tools such as Learning Labs and a Help Center, along with best practice guidance from the Benchling Customer Success team [benchling.com/customer-success]. This ensures R&D operations run smoothly and efficiently, backed by expert support and training options [benchling.com/customer-success].

Benchling is actively hiring, emphasizing its mission to transform biotech R&D by empowering scientists benchling.com/careers. The company seeks individuals passionate about making a significant impact in bringing life-changing products to market faster, building for the long term, and contributing to a culture of continuous learning and growth benchling.com/careers.

Benchling's hiring patterns indicate a strategic focus on expanding its workforce with top talent in both technology and science, evident from its leadership team which comprises experts from both fields benchling.com/leadership. The company recently brought in Chad Kalmes as CISO and CIO, signaling a commitment to bolstering security and technology transformations, particularly in the AI era benchling.com/blog/introducing-chief-information-security-officer.

Benchling also runs a dedicated University Recruiting program, underscoring its investment in new talent and the professional development of early-career professionals through mentorship and growth opportunities benchling.com/university-recruiting. This program helps new hires develop the skills, confidence, and connections needed for success in their professional lives.

While specific layoff information is not available from the provided sources, Benchling's continued growth is supported by the increasing demand for IT professionals in the biopharma industry, a sector where labs often struggle to find necessary technical skills benchling.com/news/benchling-bolsters-success-offerings-for-biotech-r-and-d-with-new-tools. This scarcity positions Benchling to attract and retain talent by offering advanced digital solutions and training.

Benchling's hiring strategy is further shaped by a commitment to diversity, equity, and inclusion (DEI), aiming to create an equitable workplace where employees feel respected, connected, and supported in their growth benchling.com/dei. This intentional approach to culture building and talent acquisition aligns with their broader mission to power breakthroughs for over 1,300 biotechnology companies globally benchling.com/contact-us.

Benchling, a cloud-based platform for biotech R&D, has demonstrated significant financial growth through multiple funding rounds and impressive revenue performance. In October 2016, the company secured $7 million in funding led by Thrive Capital Benchling Announces $7M in New Funding Led by Thrive Capital. This was followed by a $14.5 million Series B round in June 2018, led by Benchmark, at which point Benchling reported 500% Annual Recurring Revenue (ARR) growth Benchling Raises $14.5M from Benchmark to Advance Life Sciences Research.

Further accelerating its expansion, Benchling raised $34.5 million in Series C funding in July 2019, led by Menlo Ventures Benchling Raises $34.5M Series C To Fuel Life Sciences R&D. May 2020 saw a $50 million Series D funding round, led by Alkeon Benchling Raises $50M Series D To Accelerate Biotech Revolution. Financially, Benchling doubled its ARR for the fourth consecutive year by January 2021, showcasing consistent strong performance amid the COVID-19 pandemic Benchling Doubles Annual Recurring Revenue (ARR) for Fourth Straight Year Amid COVID-19 Pandemic.

Benchling continued its fundraising success in April 2021 with a $200 million Series E round led by Sequoia Capital Global Equities Benchling Raises $200M Series E To Accelerate Biotech R&D. By November 2021, the company secured an additional $100 million in Series F financing, co-led by Altimeter and Franklin Templeton, demonstrating triple-digit revenue growth and a 70% year-over-year increase in total customer count Benchling Raises $100M in Series F Financing Co-Led by Altimeter and Franklin Templeton. This consistent investment underscores confidence in Benchling's position as a leader in the life sciences R&D cloud.

Most recently, in May 2024, Benchling announced that it had crossed $200 million in annualized revenue. This milestone coincided with the appointment of Ron Gill as Chief Financial Officer and Parm Uppal as Chief Revenue Officer, signaling the company's continued focus on scaling and growth, driven by the increasing demand for its R&D Cloud platform in the evolving biotech industry Benchling Welcomes CFO Ron Gill, CRO Parm Uppal.

Benchling actively engages with its community and the broader biotech industry through a variety of events, including conferences, webinars, and specialized user gatherings. The company hosts its own significant annual event, Benchling Community Day, which in 2024 offered a first look at Benchling's roadmap and AI strategy, along with opportunities for hands-on training and networking among scientists, admins, and IT professionals [https://events.benchling.com/benchlingcommunityday]. Additionally, Benchling organizes "Benchtalk," a global gathering where R&D scientists and technology leaders from prominent companies like Bristol Myers Squibb, Eli Lilly, and Merck share strategies for digital innovation in the lab [https://www.benchling.com/news/benchtalk-convenes-r-and-d-scientists-and-technology-leaders].

The company maintains a robust schedule of webinars, providing both live and on-demand content across various use cases such as antibodies and proteins, cell therapy, gene therapy, and bioprocess development [https://www.benchling.com/webinars]. These webinars delve into topics like the impact of AI on drug discovery innovation, building AI-ready lab infrastructure, and strategies for biotech fundraising, as seen in their "Build Your Bench 2025" series [https://www.benchling.com/webinars/the-impact-of-ai-on-drug-discovery-innovation, https://www.benchling.com/webinars/build-your-bench-2025-emea]. Recent webinars have also covered exclusive first looks at the "2026 Biotech AI Report" and how AI agents are accelerating biotech innovation [https://www.benchling.com/webinars/ai-report-january-2026, https://www.benchling.com/webinars/from-concept-to-impact-how-ai-agents-are-accelerating-biotech-in].

Benchling also fosters a strong user community through user groups and online events. These groups offer platforms for professionals to connect, share ideas, solve problems, and gain expert tips, with the company actively seeking leaders to expand these groups [https://www.benchling.com/user-groups]. Upcoming community events have included "AI-Ready R&D" webinars, product Ask Me Anything (AMA) sessions with integration partners like Quilt and Code Ocean, and in-person user group meetings such as the "Benchling Philly Area User Community" [https://community.benchling.com/events?tab=upcoming]. The company also hosts virtual workshops like "Benchling Ask and Deep Research Training" to further support its users [https://community.benchling.com/events?tab=upcoming].